Pre‐RAI Monocyte‐to‐Lymphocyte Ratio Predicts Early and Higher Recurrence Risk in Intermediate‐Risk DTC, While PNI and NRI Show No Prognostic Value
Pre-RAI MLR may serve as a simple marker to refine recurrence risk stratification and personalize follow-up in intermediate-risk DTC.
Authors
- Tommaso Piticchio (ORCID: https://orcid.org/0000-0002-0567-6494)
- Francesco Pallotti (ORCID: https://orcid.org/0000-0001-9946-8516)
- Rosario Le Moli (ORCID: https://orcid.org/0000-0002-1398-9271)
- Salvatore Volpe (ORCID: https://orcid.org/0000-0001-6730-2634)
- Francesco Galeano
- Ignazio Barca
- A Scuto
- Giulio Geraci
- S. Wolde Sellasie
- Antonio Prinzi
- Francesco Frasca
Institutions
- University of Rome Tor Vergata (IT)
- Università degli Studi di Enna Kore (IT)
- Ospedale Garibaldi (IT)
- CTO Andrea Alesini (IT)
- University of Palermo (IT)
Publication Details
- Journal
- Clinical Endocrinology
- Published
- 2026-02-23
- DOI
- https://doi.org/10.1111/cen.70113
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00